China Pharma Holding Inc (CPHI)
0.2024
-0.14
(-41.33%)
USD |
OTCM |
Nov 25, 16:00
0.1853
-0.02
(-8.45%)
After-Hours: 20:00
China Pharma Total Liabilities (Quarterly): 6.937M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 6.937M |
June 30, 2024 | 6.853M |
March 31, 2024 | 7.898M |
December 31, 2023 | 9.015M |
September 30, 2023 | 9.242M |
June 30, 2023 | 11.35M |
March 31, 2023 | 12.69M |
December 31, 2022 | 13.49M |
September 30, 2022 | 13.37M |
June 30, 2022 | 13.89M |
March 31, 2022 | 15.70M |
December 31, 2021 | 16.63M |
September 30, 2021 | 11.33M |
June 30, 2021 | 13.42M |
March 31, 2021 | 12.68M |
December 31, 2020 | 13.11M |
September 30, 2020 | 13.27M |
June 30, 2020 | 14.77M |
March 31, 2020 | 14.06M |
December 31, 2019 | 13.00M |
September 30, 2019 | 12.54M |
June 30, 2019 | 14.06M |
March 31, 2019 | 14.62M |
December 31, 2018 | 15.18M |
September 30, 2018 | 14.90M |
Date | Value |
---|---|
June 30, 2018 | 17.28M |
March 31, 2018 | 17.68M |
December 31, 2017 | 16.88M |
September 30, 2017 | 17.96M |
June 30, 2017 | 19.98M |
March 31, 2017 | 19.72M |
December 31, 2016 | 19.61M |
September 30, 2016 | 22.47M |
June 30, 2016 | 25.02M |
March 31, 2016 | 25.46M |
December 31, 2015 | 23.87M |
September 30, 2015 | 25.87M |
June 30, 2015 | 26.24M |
March 31, 2015 | 26.40M |
December 31, 2014 | 28.34M |
September 30, 2014 | 25.88M |
June 30, 2014 | 25.08M |
March 31, 2014 | 24.91M |
December 31, 2013 | 24.67M |
September 30, 2013 | 19.63M |
June 30, 2013 | 14.65M |
March 31, 2013 | 12.74M |
December 31, 2012 | 14.72M |
September 30, 2012 | 16.71M |
June 30, 2012 | 16.72M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.853M
Minimum
Jun 2024
16.63M
Maximum
Dec 2021
12.14M
Average
13.06M
Median
Total Liabilities (Quarterly) Benchmarks
Linike Medical Group Ltd | 0.5317M |
China Health Industries Holdings Inc | 6.529M |
Yubo International Biotech Ltd | 4.696M |
NovaBay Pharmaceuticals Inc | 2.805M |
Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.47M |
Shareholders Equity (Quarterly) | 6.528M |
Debt to Equity Ratio | 0.6051 |
Current Ratio | 0.7855 |
Net Debt Paydown Yield | 11.97% |